Chris Picardo
Board Member
Chris is a partner at Madrona Ventures, where he identifies, evaluates and leads new investment opportunities and works closely with existing companies. Chris leads Madrona’s investments in companies innovating around the intersection of life and computer science through combining novel wet lab science with cutting-edge machine learning. His focus is on novel therapeutic platforms and software that enables companies to take advantage of the immense amount of biological data now being produced. Chris has invested in multiple inception stage biotech companies across the Seattle, San Francisco and LA markets. He is a board director at Archon Biosciences, Terray Therapeutics and two other biotech companies currently in stealth.